Clariant

Clariant Healthcare Packaging facility in India plans production operations in 2017

  • Newest India facility to make drop-in desiccant products
  • The plant contribute significantly to its global desiccant canister production
  • Facility on path toward ISO 15378 certification

Mumbai, November 21, 2016 – Clariant, a world leader in specialty chemicals, recently announced that the construction of its new greenfield production facility in Cuddalore, Tamil Nadu, India is proceeding as planned and is expected to begin production of dessicant canisters by the second semester of 2017. This plant will be a significant contributor to Clariant’s global desiccant canister production.

Clariant’s business line Healthcare Packaging had conducted the groundbreaking ceremony of this plant in January 2016. This facility will manufacture desiccant canisters, the primary desiccant platform for high-speed, high-volume packaging lines, often the case for generic drug manufacturers. In addition, Clariant is already assessing plans for expanded production, including plans to add high-capacity multi-lane production of its versatile Continu-StripTM desiccant packets, which can be inserted with numerous types of standard dessicant insertion machinery.

Clariant's extensive manufacturing footprint ensures quick delivery and competitive pricing, as well back-up capacity to meet the BCP (Business Continuity Planning) requirements of global players in the pharmaceutical industry. All products produced at the Cuddalore facility will meet US FDA and EU standards for use in pharmaceutical applications and will be USP <670> compliant. The Cuddalore facility is equipped with an ISO Class 8 clean room and will implement GMPs and environmental controls with a path toward ISO 15378 certification.

“The new site will serve the Indian pharmaceutical industry with state-of-the-art desiccant products produced under the strictest quality and compliance standards, and within a secure, truly global manufacturing network,” said Matthias Brommer, Head - Clariant Healthcare Packaging. “We are extremely excited that facility construction, and production plans are moving at full speed ahead, according to schedule. The production capabilities at this new facility will add significantly to our global dessicant canister production capacity during 2017.”

Ketan Premani, Head – Healthcare Packaging India, adds that, “The facility will also offer the full range of globally produced Clariant protective packaging systems and components and link customers to Clariant’s global packaging design capabilities. The facility and the other Healthcare Packaging facilities around the globe ensure available back-up capacity to meet the BCP (Business Continuity Planning) requirements of our global customers.”

Advanced canister mold and assembly designs ensure their ability to withstand the rigors of high speed insertion, packaging, and use. Colored labelling — including bright red — is available to help differentiate desiccant canisters from drug products.

Clariant Healthcare Packaging is the leading supplier of pharmaceutical desiccants in India, with a long history of working with both branded and generic drug manufacturers. The Cuddalore facility, the newest in the rapidly expanding global manufacturing network through which Clariant Healthcare Packaging produces and delivers its desiccant and sorbent products, joins existing production facilities in the U.S.A., France, and China. The new facility is strategically located within the Bangalore/Chennai biopharmaceutical cluster, one of India’s busiest pharmaceutical hubs, and is positioned to leverage Clariant’s existing network and logistics resources to serve customers throughout India.

Reader enquiries

Clariant International Ltd
Rothausstrasse 61
4132 Muttenz 1
Switzerland

+41 61 469 6742

www.clariant.com

@clariant

Clariant

ClariantInternational

clariant_international


Notes for editors


www.clariant.com

Clariant is a globally leading specialty chemicals company, based in Muttenz near Basel/Switzerland. On 31 December 2015 the company employed a total workforce of 17 213. In the financial year 2015, Clariant recorded sales of CHF 5.807 billion for its continuing businesses. The company reports in four business areas: Care Chemicals, Catalysis, Natural Resources, and Plastics & Coatings. Clariant’s corporate strategy is based on five pillars: focus on innovation through R&D, add value with sustainability, reposition portfolio, intensify growth, and increase profitability.

www.clariant.in

Clariant in India, headquartered in Mumbai, operates in four business areas: Care Chemicals, Catalysis & Energy, Natural Resources, and Plastics & Coatings, including businesses like Pigments (Coatings, Printing and Plastics and Special Applications), Additives, Industrial & Consumer Specialties, Mining Services and Masterbatches, thus delivering solutions for the industry and the society. The 900-plus employee strength generated sales of INR 10.08 billion (in 2014). In 2014, Clariant invested in a state-of-the-art Regional Innovation Center in Mumbai, with an aim to co-create tailormade solutions with customers for the industry.

Clariant is committed to Responsible Care® and several external sustainability initiatives such as the Global Product Strategy and the United Nations Global Compact. Clariant is one of the top European chemical companies being part of Dow Jones Sustainability Indices.

www.clariant.com/healthpack

Clariant Healthcare Packaging is dedicated to enhancing and protecting healthcare products by providing a full portfolio of controlled atmosphere packaging solutions that protect products from degradation and help maintain stability and integrity throughout shelf life. With a global production network and innovative product development, its products include desiccants, oxygen scavengers, active container-closure systems and multilayer barrier packaging.

Related images

Clariant Healthcare Packaging facility in India plans production operations in 2017. (Photo: Clariant)

 

 

Editorial enquiries

Jochen Dubiel
Clariant International Ltd

+41 61 469 63 63

jochen.dubiel@​clariant.com

Stefanie Nehlsen
Clariant International Ltd

+41 61 469 63 63

stefanie.nehlsen@​clariant.com

Josina van der Velden
EMG

+31 164 317 014

jvandervelden@​emg-marcom.com

 

Share

 

More news from